MTOR and prostate cancer: Interestingly, in a mouse model of prostate cancer driven by PI3K-AKT-mTOR hyperactivity [15], elevated protein levels of YB-1 and MTA1 were observed early in disease pathogenesis within PIN lesions prior to the development of invasion and metastasis [5].